Phase 2 Heart Disease Trial, Recruiting NCT05925634 Sponsor: Baystate Medical Center Condition: Heart Disease
Back to Heart Disease

Phase 2 Heart Disease Trial, Recruiting

NCT05925634
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have had a heart-related event in the past 6 months, such as a heart attack, heart failure, a procedure to open blocked arteries (with or without a stent), heart bypass surgery, or heart valve surgery.
  • You currently live in, or plan to live in, the Springfield, MA or greater Detroit, MI area for the next year.
  • You are being seen at a cardiac rehabilitation centre at either Baystate Medical Center or Henry Ford Health System.
  • You are 60 years old or older.
  • You are willing to attend at least 18 cardiac rehabilitation sessions after joining the trial.
  • You are willing to attend cardiac rehabilitation at least twice a week.

Who may not be able to join:

  • You have a permanent irregular heart rhythm called atrial fibrillation.
  • You have had a heart transplant.
  • You use a mechanical device to help your heart pump blood (called a left-ventricular assist device).
  • You have stable chest pain or pressure (stable angina).
  • You have serious blockages in your heart arteries that have not been treated with a procedure (confirm with trial site).
  • You have a condition affecting the arteries in your legs that causes symptoms such as pain when walking (symptomatic peripheral artery disease).
  • You have significant narrowing of the aortic or mitral heart valves.
  • You have any other condition that could make exercise testing or exercise training unsafe or difficult.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Quinn R Pack, MD, Baystate Medical Center

Phone: 413-794-5856

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Baystate Medical Center
Registry
ClinicalTrials.gov
Start date
10 August 2023
Est. completion
30 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Functional Fitness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov